Hormone Replacement Therapy (HRT) is one of those medical treatments that has quietly existed for decades, helping millions of people live healthier and more stable lives. Yet, depending on who is receiving it, HRT can be viewed either as routine healthcare or as something controversial. The difference is not in the medicine itself — it is in the social lens through which it is viewed.

At its core, HRT is simple. It is a medical treatment used when the body does not produce enough hormones on its own, or when hormone levels need adjustment for health reasons. Doctors prescribe hormones carefully, monitor patients through blood tests, and adjust doses over time. This practice is standard in modern medicine.

For example, menopause is one of the most common reasons people receive hormone therapy. Many women experience hot flashes, bone loss, mood changes, and sleep disturbances when estrogen levels decline. HRT helps stabilise these symptoms and improve quality of life. Similarly, men with low testosterone may receive hormone treatment to address fatigue, muscle loss, or low libido. Thyroid hormone replacement is another extremely common therapy, especially in countries like India, where thyroid disorders affect millions. In these cases, HRT is considered ordinary healthcare — rarely questioned and widely accepted.

The same medical science is used in transgender healthcare.

For transgender individuals, HRT plays a different but equally legitimate role. It helps reduce gender dysphoria — the distress that occurs when someone’s physical characteristics do not align with their gender identity. Transfeminine hormone therapy typically includes estrogen and medications that reduce testosterone. Over time, this can lead to breast development, softer skin, and fat redistribution. Transmasculine hormone therapy involves testosterone, which may deepen the voice, increase muscle mass, and promote facial and body hair growth.

These changes do not happen overnight. They occur gradually and under medical supervision. Regular monitoring ensures safety and helps minimise risks. Like all forms of hormone therapy, outcomes depend on dosage, age, health history, and consistent follow-up care. When prescribed and monitored properly, gender-affirming HRT is considered safe and evidence-based medical treatment.

Major professional organisations support this approach. The World Professional Association for Transgender Health (WPATH) publishes internationally recognised Standards of Care that outline how gender-affirming treatments should be provided safely and ethically. The American College of Obstetricians and Gynaecologists (ACOG) also recognises gender-affirming care as medically necessary healthcare. Research published in peer-reviewed medical journals consistently shows that access to gender-affirming hormone therapy is associated with improved mental health outcomes, including lower rates of depression and suicidal ideation.

It is important to clarify what gender-affirmation therapy is not. Talk-based gender-affirming therapy does not force anyone to transition. It does not automatically prescribe hormones. Instead, it helps individuals explore their identity, cope with distress, and make informed decisions at their own pace. Some people choose a medical transition. Others do not. The focus is safety, clarity, and well-being.

In India, however, access to safe transgender healthcare remains inconsistent. Many individuals face social stigma, a lack of trained providers, and institutional barriers. As a result, some people turn to self-medication, which increases health risks. This is not a failure of the medicine — it is a failure of access. When healthcare systems do not provide safe, supervised treatment, vulnerable populations are pushed toward unsafe alternatives.

The key point is this: hormones do not carry political beliefs. They are biological substances used in medicine for a wide range of conditions. Estrogen, testosterone, and thyroid hormones function the same way in every human body. The difference lies in how society reacts to who is receiving them.

When a cisgender woman receives estrogen for menopause, it is called treatment. When a transgender woman receives estrogen for gender dysphoria, it is sometimes called controversial. Medically, the process is similar: assessment, prescription, monitoring, and follow-up. The science does not change. The social reaction does.

Healthcare should be guided by evidence, ethics, and patient well-being — not public discomfort. HRT does not change who a person “really is.” It helps align physical traits with medical needs or identity, reducing distress and improving quality of life. Decades of clinical practice and research support its use across multiple populations.

Ultimately, hormone replacement therapy is not a cultural trend or a political experiment. It is established medicine. Like any treatment, it carries risks and benefits, which should be discussed openly between patient and provider. But when prescribed responsibly, HRT improves lives — whether for menopause, thyroid disorders, low testosterone, or gender dysphoria.

The conversation around HRT should return to where it belongs: in clinics, guided by science and compassion.

.    .    .

References:

• World Professional Association for Transgender Health (WPATH). Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. https://www.wpath.org
• American College of Obstetricians and Gynaecologists (ACOG). Health Care for Transgender and Gender Diverse Individuals. 2021. https://www.acog.org
• Johns Hopkins Medicine. Gender-Affirming Hormone Therapy Overview. https://www.hopkinsmedicine.o
• T’Sjoen G, et al. Endocrinology of Transgender Medicine. Endocrine Reviews. 2019;40(1):97–117. (PMCID: PMC5182227)
• Coleman E, et al. Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. International Journal of Transgender Health. 2022.